Tag: everlinQ endoAVF system
everlinQ endoAVF receives FDA de novo marketing approval
everlinQ endoAVF System (TVA Medical) is now approved by the US Food and Drug Administration for de novo marketing. This innovative, minimally invasive technology...
New data on quality of life and cost savings for everlinQ...
A recent healthcare analysis shows that a novel, catheter-based endovascular system for creating haemodialysis access offers quality-of-life benefits and cost savings compared to the...
TVA Medical presents positive everlinQ endoAVF system results at LINC 2017
TVA Medical has provided clinical updates involving its everlinQ endoAVF system at the 2017 Leipzig Interventional Course (LINC; 24-17 January, Leipzig, Germany).
Scientific data regarding the...
